Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.
Abstract
BACKGROUND
Both genetics and the environment are implicated as risk factors for prostate cancer (PCa). This population-based case-control
study evaluated four single-nucleotide polymorphisms (SNPs) previously identified by genome-wide association studies to be
associated with increased PCa susceptibility. Potential relationships between serum concentrations of phyto-estrogens and
SNPs were also investigated.
METHODS
Four SNPs (rs10993994, rs2660753, rs1016343 and rs6983267) were genotyped in 247 PCa patients, 125 BPH patients and 274 control
men recruited in Scotland. Serum concentrations of the phyto-estrogens enterolactone, equol, genistein and daidzein were measured
by isotope dilution gas chromatography-mass spectrometry.
RESULTS
Increased PCa risk was associated with TT genotype of rs10993994 compared with CC and CT genotypes combined (odds ratio (OR)=1.87;
95% confidence interval (CI), 1.26-2.77). TT homozygotes who had low serum enterolactone concentrations (below median) were
more likely to have PCa (OR=2.90; 95% CI, 1.28-6.57) than individuals with CC/CT genotype and high serum enterolactone concentrations
(above median). PCa was not associated with the other three SNPs tested.
CONCLUSIONS
PCa susceptibility was associated with TT genotype of SNP rs10993994 in this cohort of Scottish men and the increased risk
of PCa was modified by serum enterolactone concentrations.
Links
Authors
Ho CK, Halley L, Wei J, Habib FK
Institution
Prostate Research Group, Department of Oncology, University of Edinburgh, Edinburgh, UK. clement.ho@doctors.org.uk
Source
Prostate cancer and prostatic diseases 15:4 2012 Dec pg 365-8Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22733159
Log In

